ASSET | DATE | % RETURN |
---|---|---|
Applied Digital (APLD) | 4/13/2023 - 5/30/2023 | 187.54% |
D-Wave Quantum (QBTS) | 4/13/2023 - 5/30/2023 | 113.64% |
Arlington Asset Investment (AI) | 4/13/2023 - 5/30/2023 | 98.87% |
Rigetti Computing (RGTI) | 4/13/2023 - 5/30/2023 | 94.34% |
Soleno Therapeutics (SLNO) | 4/13/2023 - 5/30/2023 | 80.81% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 4/13/2023 - 5/30/2023 | 75.74% |
Upstart Holdings (UPST) | 4/13/2023 - 5/30/2023 | 74.61% |
Avepoint (AVPT) | 4/13/2023 - 5/30/2023 | 64.87% |
Nuvalent (NUVL) | 4/13/2023 - 5/30/2023 | 61.2% |
Immunitybio (IBRX) | 4/13/2023 - 5/30/2023 | 60.65% |
Arcellx (ACLX) | 4/13/2023 - 5/30/2023 | 53.23% |
Crispr Therapeutics (CRSP) | 4/13/2023 - 5/30/2023 | 46.09% |
Powell Industries (POWL) | 4/13/2023 - 5/30/2023 | 43.56% |
Immunovant (IMVT) | 4/13/2023 - 5/30/2023 | 43.36% |
WM Technology (MAPSW) | 4/13/2023 - 5/30/2023 | 42.37% |
Recursion Pharmaceuticals (RXRX) | 4/13/2023 - 5/30/2023 | 42.26% |
MoonLake Immunotherapeutics (MLTX) | 4/13/2023 - 5/30/2023 | 40.43% |
ACV Auctions (ACVA) | 4/13/2023 - 5/30/2023 | 40.11% |
Vaxcyte (PCVX) | 4/13/2023 - 5/30/2023 | 39.57% |
Crinetics Pharmaceuticals (CRNX) | 4/13/2023 - 5/30/2023 | 39.38% |
Krystal Biotech (KRYS) | 4/13/2023 - 5/30/2023 | 38.44% |
Joby Aviation (JOBY) | 4/13/2023 - 5/30/2023 | 37.5% |
Green Brick Partners (GRBK) | 4/13/2023 - 5/30/2023 | 37.01% |
Protagonist Therapeutics (PTGX) | 4/13/2023 - 5/30/2023 | 35.91% |
Onto Innovation (ONTO) | 4/13/2023 - 5/30/2023 | 33.1% |